x@ Table of content
x@ x@
,Chapter I Issues for the Practitioner in Drug Therapy
x@ x@ x@ x@ x@ x@ x@ x@
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Princip
x@ x@ x@ x@ x@ x@ x@ x@
les Chapter 3 Impact of Drug Interactions and Adverse Events on Therape
x@ x@ x @ x@ x@ x@ x @ x@ x@ x @ x@
utics Chapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
Lactation Chapter 5 Pharmacotherapy Principles in Older Adults
x@ x@ x@ x@ x@ x@ x@
Chapter 6 Principles of Antimicrobial Therapy Cha
x@ x@ x@ x@ x@ x@
pter 7 Pharmacogenomies
x@ x@
Chapter 8 The Economics of Pharmacotherapeutics
x@ x@ x@ x@ x@ x
@Chapter 9 Pharmacotherapy of Pain Management
x@ x@ x@ x@ x@
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patie
x@ x@ x@ x@ x@ x@ x@ x@ x@
nts Chapter 11 Cannabis and Pain Management
x@ x@ x@ x@ x@ x@
Chapter 12 Contact Dermatitis
x@ x@ x@
Chapter 13 Fungal, Viral, and Bacterial Infections of the S
x@ x@ x@ x@ x@ x@ x@ x@ x@
kin Chapter 14 Psoriasis
x@ x@ x@
Chapter I5 Acne Vulgaris and Rosacea Ch
x@ x@ x@ x@ x@ x@
apter 16 Ophthalmic Disorders
x@ x@ x@
Chapter I7 Otitis Media and Otitis Externa
x@ x@ x@ x@ x@ x@ x
@Chapter I8 Hypertension x@ x@
Chapter I9 Hyperlipidemiax@ x@
Chapter 20 Chronic Stable Angina and Myocardial Infarcti
x@ x@ x@ x@ x@ x@ x@
on Chapter 2I Heart Failure
x@ x@ x@ x@
Chapter 22 Arrhythmias x@ x@
Chapter 23 Respiratory Infections
x@ x@ x@
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease C
x@ x@ x@ x@ x@ x@ x@ x@
hapter 25 Gastric, Functional, and Inflammatory Bowel Disorders
x@ x@ x@ x@ x@ x@ x@ x@
Chapter 26 Gastroesophageal Reflux Disease and Peptic Ulcer Dise
x@ x@ x@ x@ x@ x@ x@ x@
ase Chapter 27 Liver Diseases
x@ x@ x@ x@
Chapter 28 Urinary Tract Infection
x@ x@ x@ x@
Chapter 29 Prostatic Disorders and Erectile Dysfunction Ch
x@ x@ x@ x@ x@ x@ x@
apter 30 Overactive Bladder
x@ x@ x@
Chapter 3I Sexually Transmitted Infectio
x@ x@ x@ x@
ns Chapter 32 Osteoarthritis and Gout
x@ x@ x@ x@ x@ x@
Chapter 33 Osteoporosis x@ x@
Chapter 34 Rheumatoid Arthritis
x@ x@ x@ x
@Chapter 35 Headaches x@ x@
Chapter 36 Seizure Disorders
x@ x@ x@
Chapter 37 Alzheimer's Diseas
x@ x@ x@ x@
e Chapter 38 Parkinson's Di
x @ x@ x@ x@
sease
Chapter 39 Major Depressive Disorder and Bipolar Disorde
x@ x@ x@ x@ x@ x@ x@
rs Chapter 40 Anxiety Disorders
x@ x@ x@ x@
Chapter 41 Sleep Disorders
x@ x @ x @
Chapter 42 Attention Deficit Hyperactivity Disorde
x@ x@ x@ x@ x@
r Chapter 43 Substance Use Disorders
x@ x@ x@ x@ x@
Chapter 44 Diabetes Mellitus
x@ x@ x@
Chapter 45 Thyroid and Parathyroid Disorders
x@ x@ x@ x@ x@
,Chapter 46 Allergies and Allergic Reactio
x@ x@ x@ x@ x@
ns Chapter 47 Human Immunodeficiency
x@ x@ x@ x@ x@
Virus Chapter 48 Organ Transplantation
x@ x@ x@ x@
Chapter 49 Thromboembolic Disorders C
x@ x@ x@ x@
hapter 50 Anemias x@ x@
Chapter 5l Immunizations Cha
x@ x@ x@
pter 52 Smoking Cessation Ch
x@ x@ x@ x@
apter 53 Weight Loss Chapter
x@ x@ x@ x@
54 Contraception
x@ x@
Chapter 55 Menopause x@ x@
Chapter 56 Vaginitis x@ x@
, x@
x @ x@
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
x@ x@ x@ x@ x@ x@ x@ x@
MULTIPLE CHOICE
x@
1. Nurse practitioner prescriptive authority is regulated by:
x@ x@ x@ x@ x@ x@
A. The National Council of State Boards of Nursing
x@ x@ x@ x@ x@ x@ x@
B. The U.S. Drug Enforcement Administration
x@ x@ x@ x@
C. The State Board of Nursing for each state
x@ x@ x@ x@ x@ x@ x@
D. The State Board of Pharmacy
x@ x@ x@ x@
ANS: x @ C PTS: x @ 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
x@ x@ x@ x@ x@ x@ x@
A. The National Council of State Boards of Nursing
x@ x@ x@ x@ x@ x@ x@
B. The U.S. Drug Enforcement Administration
x@ x@ x@ x@
C. The State Board of Nursing
x@ x@ x@ x@
D. The State Board of Medical Examiners
x@ x@ x@ x@ x@
ANS: x @ D PTS: x @ 1
3. Clinical judgment in prescribing includes:
x@ x@ x@ x@
A. Factoring in the cost to the patient of the medication prescribed
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
B. Always prescribing the newest medication available for the disease process
x@ x@ x@ x@ x@ x@ x@ x@ x@
C. Handing out drug samples to poor patients
x@ x@ x@ x@ x@ x@
D. Prescribing all generic medications to cut costs
x@ x@ x@ x@ x@ x@
ANS: x @ A PTS: x @ 1
4. Criteria for choosing an effective drug for a disorder include:
x@ x@ x@ x@ x@ x@ x@ x@ x@
A. Asking the patient what drug they think would work best for them
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
B. Consulting nationally recognized guidelines for disease management
x@ x@ x@ x@ x@ x@
C. Prescribing medications that are available as samples before writing a prescription
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
D. Following U.S. Drug Enforcement Administration (DEA) guidelines
x@ x@ x@ x@ x@ x@ x@
for prescribing
x@
ANS: x @ B PTS: x @ 1
5. Nurse practitioner practice may thrive under health-care reform due to:
x@ x@ x@ x@ x@ x@ x@ x@ x@
A. The demonstrated ability of nurse practitioners to control costs and improve p
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
atient outcomes x@
B. The fact that nurse practitioners will be able to practice independently
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
C. The fact that nurse practitioners will have full reimbursement under health
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
-care reform x@
D. The ability to shift accountability for Medicaid to the state level
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
ANS: x @ A PTS: x @ 1
x@ x@
,Chapter I Issues for the Practitioner in Drug Therapy
x@ x@ x@ x@ x@ x@ x@ x@
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Princip
x@ x@ x@ x@ x@ x@ x@ x@
les Chapter 3 Impact of Drug Interactions and Adverse Events on Therape
x@ x@ x @ x@ x@ x@ x @ x@ x@ x @ x@
utics Chapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
Lactation Chapter 5 Pharmacotherapy Principles in Older Adults
x@ x@ x@ x@ x@ x@ x@
Chapter 6 Principles of Antimicrobial Therapy Cha
x@ x@ x@ x@ x@ x@
pter 7 Pharmacogenomies
x@ x@
Chapter 8 The Economics of Pharmacotherapeutics
x@ x@ x@ x@ x@ x
@Chapter 9 Pharmacotherapy of Pain Management
x@ x@ x@ x@ x@
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patie
x@ x@ x@ x@ x@ x@ x@ x@ x@
nts Chapter 11 Cannabis and Pain Management
x@ x@ x@ x@ x@ x@
Chapter 12 Contact Dermatitis
x@ x@ x@
Chapter 13 Fungal, Viral, and Bacterial Infections of the S
x@ x@ x@ x@ x@ x@ x@ x@ x@
kin Chapter 14 Psoriasis
x@ x@ x@
Chapter I5 Acne Vulgaris and Rosacea Ch
x@ x@ x@ x@ x@ x@
apter 16 Ophthalmic Disorders
x@ x@ x@
Chapter I7 Otitis Media and Otitis Externa
x@ x@ x@ x@ x@ x@ x
@Chapter I8 Hypertension x@ x@
Chapter I9 Hyperlipidemiax@ x@
Chapter 20 Chronic Stable Angina and Myocardial Infarcti
x@ x@ x@ x@ x@ x@ x@
on Chapter 2I Heart Failure
x@ x@ x@ x@
Chapter 22 Arrhythmias x@ x@
Chapter 23 Respiratory Infections
x@ x@ x@
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease C
x@ x@ x@ x@ x@ x@ x@ x@
hapter 25 Gastric, Functional, and Inflammatory Bowel Disorders
x@ x@ x@ x@ x@ x@ x@ x@
Chapter 26 Gastroesophageal Reflux Disease and Peptic Ulcer Dise
x@ x@ x@ x@ x@ x@ x@ x@
ase Chapter 27 Liver Diseases
x@ x@ x@ x@
Chapter 28 Urinary Tract Infection
x@ x@ x@ x@
Chapter 29 Prostatic Disorders and Erectile Dysfunction Ch
x@ x@ x@ x@ x@ x@ x@
apter 30 Overactive Bladder
x@ x@ x@
Chapter 3I Sexually Transmitted Infectio
x@ x@ x@ x@
ns Chapter 32 Osteoarthritis and Gout
x@ x@ x@ x@ x@ x@
Chapter 33 Osteoporosis x@ x@
Chapter 34 Rheumatoid Arthritis
x@ x@ x@ x
@Chapter 35 Headaches x@ x@
Chapter 36 Seizure Disorders
x@ x@ x@
Chapter 37 Alzheimer's Diseas
x@ x@ x@ x@
e Chapter 38 Parkinson's Di
x @ x@ x@ x@
sease
Chapter 39 Major Depressive Disorder and Bipolar Disorde
x@ x@ x@ x@ x@ x@ x@
rs Chapter 40 Anxiety Disorders
x@ x@ x@ x@
Chapter 41 Sleep Disorders
x@ x @ x @
Chapter 42 Attention Deficit Hyperactivity Disorde
x@ x@ x@ x@ x@
r Chapter 43 Substance Use Disorders
x@ x@ x@ x@ x@
Chapter 44 Diabetes Mellitus
x@ x@ x@
Chapter 45 Thyroid and Parathyroid Disorders
x@ x@ x@ x@ x@
,Chapter 46 Allergies and Allergic Reactio
x@ x@ x@ x@ x@
ns Chapter 47 Human Immunodeficiency
x@ x@ x@ x@ x@
Virus Chapter 48 Organ Transplantation
x@ x@ x@ x@
Chapter 49 Thromboembolic Disorders C
x@ x@ x@ x@
hapter 50 Anemias x@ x@
Chapter 5l Immunizations Cha
x@ x@ x@
pter 52 Smoking Cessation Ch
x@ x@ x@ x@
apter 53 Weight Loss Chapter
x@ x@ x@ x@
54 Contraception
x@ x@
Chapter 55 Menopause x@ x@
Chapter 56 Vaginitis x@ x@
, x@
x @ x@
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
x@ x@ x@ x@ x@ x@ x@ x@
MULTIPLE CHOICE
x@
1. Nurse practitioner prescriptive authority is regulated by:
x@ x@ x@ x@ x@ x@
A. The National Council of State Boards of Nursing
x@ x@ x@ x@ x@ x@ x@
B. The U.S. Drug Enforcement Administration
x@ x@ x@ x@
C. The State Board of Nursing for each state
x@ x@ x@ x@ x@ x@ x@
D. The State Board of Pharmacy
x@ x@ x@ x@
ANS: x @ C PTS: x @ 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
x@ x@ x@ x@ x@ x@ x@
A. The National Council of State Boards of Nursing
x@ x@ x@ x@ x@ x@ x@
B. The U.S. Drug Enforcement Administration
x@ x@ x@ x@
C. The State Board of Nursing
x@ x@ x@ x@
D. The State Board of Medical Examiners
x@ x@ x@ x@ x@
ANS: x @ D PTS: x @ 1
3. Clinical judgment in prescribing includes:
x@ x@ x@ x@
A. Factoring in the cost to the patient of the medication prescribed
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
B. Always prescribing the newest medication available for the disease process
x@ x@ x@ x@ x@ x@ x@ x@ x@
C. Handing out drug samples to poor patients
x@ x@ x@ x@ x@ x@
D. Prescribing all generic medications to cut costs
x@ x@ x@ x@ x@ x@
ANS: x @ A PTS: x @ 1
4. Criteria for choosing an effective drug for a disorder include:
x@ x@ x@ x@ x@ x@ x@ x@ x@
A. Asking the patient what drug they think would work best for them
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
B. Consulting nationally recognized guidelines for disease management
x@ x@ x@ x@ x@ x@
C. Prescribing medications that are available as samples before writing a prescription
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
D. Following U.S. Drug Enforcement Administration (DEA) guidelines
x@ x@ x@ x@ x@ x@ x@
for prescribing
x@
ANS: x @ B PTS: x @ 1
5. Nurse practitioner practice may thrive under health-care reform due to:
x@ x@ x@ x@ x@ x@ x@ x@ x@
A. The demonstrated ability of nurse practitioners to control costs and improve p
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
atient outcomes x@
B. The fact that nurse practitioners will be able to practice independently
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
C. The fact that nurse practitioners will have full reimbursement under health
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
-care reform x@
D. The ability to shift accountability for Medicaid to the state level
x@ x@ x@ x@ x@ x@ x@ x@ x@ x@
ANS: x @ A PTS: x @ 1